Perelman School of Medicine at the U. of Pennsylvania
The well-acknowledged gender gap in startup funding has prompted previous studies to propose gender diversity in the investment community as a potential solution. However, these studies often lack a comprehensive analysis of the underlying reasons influencing investor decision-making. Drawing on existing empirical evidence regarding the neurological foundations of investor behavior, we theorize that neuro-chemistry among investors plays a crucial role in predicting investor interest in entrepreneurial projects. By exploring these dynamics, our study aims to provide neurological insights that might reconcile the varied empirical results found in previous studies emphasizing gender diversity. Additionally, we provide detailed methodological considerations for future research, including the neuroforecasting approach, which has proven valuable in predicting organizational outcomes, such as consumer choices.
